Ortin Global Ltd.

12.8

0.3 (2.3%)growUp

ORTINGLOBE Share Price
As on January 27, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap10 Cr
P/E Ratio-12.3
Dividend YieldN/A
Trendline Performance

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open11.9
High12.98
NSE SymbolORTINGLOBE
Close12.8
Low11.9
BSE Symbol539287
Previous Years High/Low
1 Year High18.93
3 Year High30.35
5 Year High52.25
1 Year Low9.64
3 Year Low9.64
5 Year Low9.64

Technicals


IndicatorsValueSignal
5-DMA12.52Bullish
10-DMA12.93Bearish
20-DMA13.31Bearish
50-DMA13.24Bearish
100-DMA12.59Bullish
200-DMA12.35Bullish

Historical Performance


1 Year
-18.9%
3 Years
-45.6%
5 Years
-58.7%
10 Years
-41.1%

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:-5.5
5 Years:N/A
3 Years:-18.4
TTM:-17.9
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a low PE of -12.3, which may indicate undervaluation or subdued growth expectations.
  • Over the last three years, the stock delivered a weak 3-year price CAGR of -18.7%, indicating poor shareholder returns.
  • The stock carries a low beta of 0.4, suggesting lower volatility than the broader market.
  • In the last financial year, the company reported a negative or negligible EBITDA of ₹-8 million, indicating weak operating profitability.
  • In the previous financial year, the company generated revenue of ₹3 million, indicating a relatively small business scale.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 821039.1
No. of Shares: 64144 (Approx)
Performance:-17.9%
P/L: ₹-178960.9
NIFTY Performance: 9.7%
1 day Top Gainers
SymbolChange%
HOMEFIRST1251.7(13%)
KARURVYSYA292.55(10%)
JSL810.05(9%)
SONACOMS487.8(7%)
GRSE2387.6(7%)
1 Day Top Losers
SymbolChange%
SBFC89.97(-12%)
SYNGENE489.7(-10%)
JSWENERGY440.05(-8%)
SUNTV529.9(-6%)
GODREJCP1173.9(-5%)
GRAVITA1466.3(-5%)
CREDITACC1320.6(-5%)
NUVAMA1265.2(-5%)

Top Performing Stocks from the same sector


Mangalam Drugs And Organics Ltd.

77.5%

42.21

1 Month Performance

NGL Fine-Chem Ltd.

18.4%

1566.2

1 Month Performance

Ind-Swift Laboratories Ltd.

16.9%

107.02

1 Month Performance

Torrent Pharmaceuticals Ltd.

4.7%

3997.4

1 Month Performance

Acutaas Chemicals Ltd.

4.5%

1728

1 Month Performance

Emcure Pharmaceuticals Ltd.

4%

1484.6

1 Month Performance

Alkem Laboratories Ltd.

4%

5754

1 Month Performance

Aarti Pharmalabs Ltd.

3.2%

766.5

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month